Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL £41
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC

Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  2. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  3. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  4. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  5. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  6. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  7. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  8. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  9. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  10. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  11. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  12. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  13. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  14. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  15. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  16. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  17. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  18. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  19. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  20. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  21. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  22. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  23. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  24. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  25. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  26. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  27. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  28. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  29. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  30. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  31. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  32. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  33. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  34. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  35. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  36. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  37. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  38. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  39. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  40. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  41. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  42. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  43. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  44. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  45. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  46. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  47. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  48. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  49. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  50. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  51. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  52. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  53. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  54. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  55. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  56. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  57. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  58. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  59. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  60. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  61. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  62. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  63. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  64. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  65. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  66. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  67. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  68. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  69. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  70. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  71. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  72. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  73. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  74. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  75. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  76. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  77. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  78. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  79. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  80. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  81. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  82. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  83. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  84. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  85. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  86. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  87. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  88. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  89. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  90. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  91. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  92. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  93. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  94. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  95. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  96. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  97. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  98. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  99. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  100. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  101. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  102. Ma K, et al. 2022. iScience. 25:104347. PubMed
  103. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  104. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  105. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  106. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  107. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  108. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  109. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  110. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  111. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  112. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  113. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  114. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  115. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  116. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  117. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  118. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  119. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  120. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  121. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  122. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  123. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  124. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  125. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  126. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  127. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  128. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  129. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  130. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  131. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  132. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  133. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  134. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  135. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  136. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  137. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  138. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  139. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  140. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  141. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  142. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  143. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  144. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  145. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  146. Wang X, et al. 2022. Elife. 11:. PubMed
  147. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  148. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  149. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  150. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  151. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  152. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  153. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  154. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  155. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  156. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  157. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  158. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  159. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  160. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  161. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  162. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account